Literature DB >> 25840748

High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia.

Louise Kristensen1, Thomas Kristensen1, Niels Abildgaard2, Mads Thomassen3, Mikael Frederiksen4, Torben Mourits-Andersen5, Michael Boe Møller6.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia among adults in the Western world. Autophagy is a highly conserved process in eukaryotic cells. In CLL autophagy is involved in mediating the effect of chemotherapy but the role of autophagy in CLL pathogenesis remains unknown. In the present study, we used real-time RT-PCR to analyze expression of the PIK3C3, PIK3R4, and BECN1 genes. These genes encode the components of the PI3K core complex, which is central to initiation of autophagy. A consecutive series of 149 well-characterized CLL cases from Region of Southern Denmark were included in the study. All three genes were observed to be independent markers of prognosis in CLL with high expression being associated with more aggressive disease. With this clear association with outcome in CLL, these genes thereby represent promising candidates for future functional studies on the role of autophagy in CLL, and they may further represent targets of treatment.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autophagy; BECN1; Chronic lymphocytic leukemia; PIK3C3; PIK3R4; Prognosis

Mesh:

Substances:

Year:  2015        PMID: 25840748     DOI: 10.1016/j.leukres.2015.02.008

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  8 in total

1.  Clinical significance of BECLIN1 and ATG5 expression in acute myeloid leukemia patients.

Authors:  Yun Lian; Yue Xie; Ming Hong; Yu Zhu; Huihui Zhao; Xiaoli Zhao; Han Zhu; Chun Qiao; Jianyong Li; Sixuan Qian
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 2.  Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma.

Authors:  Mojgan Djavaheri-Mergny; Sylvie Giuriato; Mario P Tschan; Magali Humbert
Journal:  Cells       Date:  2019-01-30       Impact factor: 6.600

Review 3.  The Role of Phosphatidylinositol 3-Kinase Catalytic Subunit Type 3 in the Pathogenesis of Human Cancer.

Authors:  Chien-An Chu; Yi-Wen Wang; Yi-Lin Chen; Hui-Wen Chen; Jing-Jing Chuang; Hong-Yi Chang; Chung-Liang Ho; Chen Chang; Nan-Haw Chow; Chung-Ta Lee
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

4.  Structure and flexibility of the endosomal Vps34 complex reveals the basis of its function on membranes.

Authors:  Ksenia Rostislavleva; Nicolas Soler; Yohei Ohashi; Lufei Zhang; Els Pardon; John E Burke; Glenn R Masson; Chris Johnson; Jan Steyaert; Nicholas T Ktistakis; Roger L Williams
Journal:  Science       Date:  2015-10-09       Impact factor: 47.728

5.  Increased Expression of Autophagy Protein LC3 in Two Patients With Progressing Chronic Lymphocytic Leukemia.

Authors:  Daniela S Arroyo; Cecilia M Rodriguez; Claudio Bussi; Clarisa Manzone-Rodriguez; Darío Sastre; Viviana Heller; Carmen Stanganelli; Irma Slavutsky; Pablo Iribarren
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-22       Impact factor: 5.555

6.  Integrated multi-omics data analysis identifying novel drug sensitivity-associated molecular targets of hepatocellular carcinoma cells.

Authors:  Gokhan Yildiz
Journal:  Oncol Lett       Date:  2018-05-04       Impact factor: 2.967

7.  PIK3C3 Acts as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and Was Regulated by MiR-340-5p.

Authors:  Xiaobo Wang; Min Gu; Yongjian Ju; Juying Zhou
Journal:  Med Sci Monit       Date:  2020-03-24

8.  IGHV-associated methylation signatures more accurately predict clinical outcomes of chronic lymphocytic leukemia patients than IGHV mutation load.

Authors:  Dianna Hussmann; Anna Starnawska; Louise Kristensen; Iben Daugaard; Astrid Thomsen; Tina E Kjeldsen; Christine Søholm Hansen; Jonas Bybjerg-Grauholm; Karina Dalsgaard Johansen; Maja Ludvigsen; Thomas Kristensen; Thomas Stauffer Larsen; Michael Boe Møller; Charlotte Guldborg Nyvold; Lise Lotte Hansen; Tomasz K Wojdacz
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.